Home / Community / News


04/16/2013 - 10:54am

Maurice Swanson, Ph.D., Professor of Molecular Genetics and Microbiology at University of Florida, Gainesville, and a team of researchers have found that the muscleblind-like 2 (MBNL2) protein in the central nervous system (CNS) may be responsible for the neurological impacts of myotonic dystrophy

03/19/2013 - 11:56am

We recently talked about the development of Stanford's new Center for DM Care and Research with Dr. John Day, Professor of Neurology and & Neurological Sciences and Director of the Division of Neuromuscular Medicine and Neuromuscular Clinics at Stanford University.

MDFR Screenshot
02/27/2013 - 4:31pm

MENLO PARK, CA (February 28, 2013) The Myotonic Dystrophy Foundation (MDF) announced today that it has launched the Myotonic Dystrophy Family Registry (MDFR), a new online database designed to help both individuals living with myotonic dystrophy (DM), and the researchers and medical professionals studying the rare disease.

02/19/2013 - 11:02am

On Rare Disease Day 2013 -- February 28th -- you'll be able to take a more active role in the fight against myotonic dystrophy (DM) by joining the new Myotonic Dystrophy Family Registry (MDFR).

01/23/2013 - 6:16pm

Methylphenidate, a psycho-stimulant drug, also known by its 1948 trademarked name of Ritalin, could be useful in the treatment of excessive daytime sleepiness (EDS) for DM1 patients, according to a recent study conducted by The Department of Human Genetics at the Centre Hospitalier Universitaire de Quebec in Quebec City, Canada.


© Myotonic Dystrophy Foundation. All rights reserved.